¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"alpha chain disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • febrile disease
    ¿­º´
  • fibrocystic disease
    ¼¶À¯³¶º´
  • fifth disease
    Á¦5º´, °¨¿°È«¹Ý
  • Fahr disease
    ÆÄ¸£º´
  • fluke disease
    ÈíÃæº´
  • foot process disease
    ¹ßµ¹±âº´
  • foot-and-mouth disease
    ÀԹߺ´, ±¸Á¦¿ª
  • Fordyce¡¯s disease
    Æ÷´ÙÀ̽ºº´
  • functional cardiovascular disease
    ±â´É¼º½É(Àå)Ç÷°üº´
  • fungal disease
    Áø±ÕÁúȯ, °õÆÎÀ̺´
  • fusospirochetal disease
    ¹æÃß±Õ½ºÇÇ·ÎÇ쟺´
  • gastroesophageal reflux disease
    À§½Äµµ¿ª·ùº´
  • genetic disease
    À¯Àüº´
  • gestational trophoblastic disease
    Àӽſµ¾ç¸·º´
  • glomerular disease
    Å丮º´, »ç±¸Ã¼Áúȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • functional cardiovascular disease
    ±â´É½ÉÀåÇ÷°üº´
  • fungal disease
    Áø±Õº´, Áø±ÕÁúȯ, °õÆÎÀ̺´
  • gastroesophageal reflux disease
    À§½Äµµ¿ª·ùº´
  • generalized obstructive lung disease
    ¹ü¹ßÆó¼âÆóº´
  • genetic disease
    À¯Àüº´
  • gestational trophoblastic disease
    Àӽſµ¾ç¸ð¼¼Æ÷º´
  • glucose storage disease
    ´çÃàÀûº´
  • glycogen storage disease
    ´ç¿øÃàÀûº´
  • graft-versus-host disease
    À̽Ĵë¼÷ÁÖº´
  • granulomatous disease
    À°¾ÆÁ¾º´
  • hand-foot-mouth disease
    ¼Õ¹ßÀÔº´
  • Hansen¡¯s disease
    (¢¡leprosy) ³ªº´
  • hard pad disease
    °æÃ´Áõ
  • heart disease
    ½ÉÀ庴
  • heart muscle disease
    ½ÉÀå±ÙÀ°º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • Fordyce s disease
    Æ÷¿À´ÙÀ̽ºº´.
  • Fordyces disease
    Æ÷´ÙÀ̽ºº´
  • Fordyces disease
    Æ÷¿À´ÙÀ̽ºº´
  • Fox Fordyce disease
    Æø½º-Æ÷´ÙÀ̽ºº´
  • Gauchers disease
    °í¼Îº´
  • Gerstmann-Strauissler-Scheinker disease(GSS)
    °Ô¸£½ºÆ®¸¸ ½´Åõ·ÎÀ̽½·¯ »þÀ×Ä¿ º´
  • Gilchrist disease
    ±æÅ©¸®½ºÆ®º´
  • Gilchrists disease => North American blastomycosis
    ºÏ¾Æ¸Þ¸®Ä« ºÐ¾Æ Áø±ÕÁõ
  • Graves disease
    ±×·¹À̺꽺 º´
  • Graves disease
    ±×·¹À̺꾾º´(Ü»)
  • Graves disease
    ±×¶óºê½ºº´
  • Graves disease
    ±×·¹À̺꽺º´
  • Grovers disease => transient acantholytic dermatosis
    Àϰú¼º ±Ø¼¼Æ÷ÇØ¸® ÇǺÎÁõ
  • Gunthers disease => congenital erythropoietic porphyria
    ¼±Ãµ¼º ÀûÇ÷±¸ Á¶Ç÷¼º Æ÷¸£ÇǸ° Áõ
  • Hailey-Hailey disease = familial benign chronic pemphigus
    ÇìÀϸ®-ÇìÀϸ®º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • acute demyelinating disease
    ±Þ¼º Å»¼öÃʼº Áúȯ(¡­÷­âÐõ¦àõòðü´).
  • acute febrile neutrophilic dermatosis ; Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ.
  • acute febrile neutrophilic dermatosis = Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ
  • acute infectious disease
    ±Þ¼º °¨¿°Áúȯ
  • acute infectious disease =AID
    ±Þ¼º Àü¿°º´(¡­îîæøÜ»).
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • addisons disease
    ¾Öµð½¼º´(¡­Ü»)
  • addisons disease
    ¾Öµð½¼º´<<ºÎ½Å±â´ÉºÎÀü>>
  • adipose tissue disease
    Áö¹æÁ¶Á÷Áúȯ.
  • adjuvant disease
    ¾ÖÁÖ¹øÆ®º´.
  • adrenal cortex disease
    ºÎ½ÅÇÇÁúÁúȯ(Üùãìù«òõòðü´).
  • adult disease
    ¼ºÀκ´(à÷ìÑÜ»).
  • african sleeping disease
    ¾ÆÇÁ¸®Ä« ¼ö¸éº´(¡­â²ØùÜ»)
  • air borne disease
    °ø±â¸Å°³Áúȯ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
WD wallerian degeneration; well developed; well differentiated; wet dressing; Whitney Damon [dextrose];...
AMD acid maltase deficiency; acromandibular dysplasia; actinomycin D; adrenomyelodystrophy; age-related ...
AH   1) Atrial Hypertrophy
  2) Anti-Hyaluronidase
  3) Amyloid imm...
AL Amyloid immunoglobulin Light chain protein
BCAA Branched Chain Amino Acid
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
alpha-CGRP Alpha calcitonin gene-related peptide
alpha-GST Alpha glutathione S-transferase
alpha-hANP Alpha human atrial natriuretic polypeptide
IFN alpha Alpha interferon
alpha IFN Alpha interferon
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Hansen's disease
    ÇѼ¾º´, ³ªº´
    ÁÖ·Î ÇÇºÎ¿Í ¸»ÃʽŰæÀ» ħ¹üÇÏ´Â ¸¸¼º À°¾ÆÁ¾¼º °¨¿°ÀÇ ÀÏÁ¾. Mycobacterium le
  • Hartnup disease
    Çϸ£Æ®´©ÇÁ º´
    À¯Àü¼º
  • Hashimoto's disease
    ÇϽø𵵠º´
    °©»ó¼±ÀÇ ÁøÇ༺ ÀÚ°¡ ¸é¿ª ÁúȯÀ¸·Î¼­ ¸²ÇÁ±¸ ħÀ±°ú ¼øÈ¯Áß ÀÚ°¡ Ç×ü¸¦ µ¿¹ÝÇÑ´Ù. ¿©ÀÚ¿¡°Ô Àß ÀϾ°í °¡°èÀû ¼ÒÀÎ °æÇâÀÌ ÀÖ´Ù. ¶§·Î´Â °©»ó¼± ±â´É Ç×ÁøÁõ¿¡ ÈļÓÇÏ¿© ³ªÅ¸³ª¸ç, ȯÀÚ´Â °©»ó¼± Á¾´ë¸¦ ÀÏÀ¸Å°°í Á¡ÁøÀûÀ¸·Î °©»ó¼± ±â´É ÀúÇÏ »óÅ¿¡ ºüÁø´Ù.
  • heart disease
    ½ÉÀå º´, ½É Áúȯ
    ¼øÈ¯±â Áúȯ Áß ½ÉÀåÀÇ Áúȯ. ÀϹÝÀûÀ¸·Î °ü Ç÷°üÀ̳ª ½ÉÀåÀÇ º´µµ Æ÷ÇԵȴÙ. º´º¯ÀÇ ºÎÀ§¿¡ ÀÇÇÑ º´¸®ÇغÎÇÐÀû ºÐ·ù¿Í º´Àο¡ ÀÇÇÑ ºÐ·ù°¡ ÀÌ·ç¾îÁö°í ÀÖ´Ù. ÀüÀÚ´Â ¼ö ½Ê ³â ÀüºÎÅÍ ¾²¿©Á® ¿ÔÀ¸³ª ±Ù³â¿¡ ¿Í¼­ º»ÁúÀûÀÎ ¿øÀÎ ¿ä¹ýÀÌ °¡´ÉÇÏ°Ô µÈ ÀÌÈÄ´Â ÈÄÀÚÀÇ ºÐ·ù°¡ ÀÇÀǰ¡ À־ ¸¹ÀÌ ¾²ÀÌ°Ô µÇ¾ú´Ù. º´º¯ ºÎÀ§·Î´Â ½É³»¸·
  • hematologic disease
    Ç÷¾× Áúȯ
  • hematopoietic disease
    Á¶Ç÷ Áúȯ, Á¶Ç÷¼º Áúȯ
    Ç÷°üÀ̳ª Ç÷¾× ¼ººÐÀ» »ý¼ºÇÏ´Â µ¥ ÀÖ¾î ¹®Á¦¸¦ ÀÏÀ¸Å°´Â Áúº´.
  • hemic disease
    Ç÷¾× Áúȯ
  • hemolytic disease
    ¿ëÇ÷¼º Áúȯ
  • hepatocerebral disease
    °£ ³ú ÁõÈıº
    Àª½¼ º´°ú À̳뼼ÇüÀ¸·Î Å©°Ô ³ª´­ ¼ö ÀÖ´Ù. Àª½¼ º´Àº ¼±Ãµ¼ºÀÎ °áÇÔÀ¸·Î ÀÎÇÑ ±¸¸® ´ë»ç ÀÌ»óÀ¸·Î¼­, °£ ¹× ³ú¿¡ ´Ù·®ÀÇ ±¸¸®°¡ Ä§ÂøÇÑ´Ù. °£Àº ÇöÀúÇÑ °æº¯ÁõÀ» ³ªÅ¸³»°í, °£ ±â°£ºÎÀÇ ·»Áî ÇÙÀ̳ª Çǰ¢ µî¿¡ º¯¼ºÀÌ »ý±ä´Ù. ÇÇ, ¿ÀÁÜ ¼ÓÀÇ ±¸¸®´Â ºÒ¾î³ª³ª, Ç÷¾× ¼ÓÀÇ ±¸¸® °áÇÕ ´Ü¹éÁúÀÎ ¼¿·ê·Î Çö󽺹ÎÀº °¨¼ÒÇÏ°í °¢¸·¿¡ Ä«ÀÌÀú ÇöóÀ̼ŠȯÀÌ »ý±ä´Ù. À̳뼼Çü Áß °£ ¿ÜÇüÀº °£ Áúȯ ½Ã¿¡ °£ ³» Ç÷·ù°¡ °ï¶õÇÏ°Ô µÈ °á°ú, °£ ¿ÜÀÇ ´Ü¶ôÀ» ÅëÇÏ¿© ³»¸ÆÇ÷ÀÌ ±×´ë·Î ½ºÃÄ Áö³ª°¡±â ¶§¹®¿¡ Ç÷¾× ¼ÓÀÇ ¾Ï¸ð´Ï¾Æ °ªÀÌ »ó½ÂÇÏ¿© ³ú Áõ»óÀ» ÀÏÀ¸Å²´Ù. °£³»ÇüÀº ÁÖ·Î Áö¹æ¼º °£ °æº¯Áõ µî¿¡¼­ °£ ³»ÀÇ ´Ü¶ôÀ» ±×´ë·Î ºüÁ®³ª°¡±â ¶§¹®¿¡ À§¿Í °°Àº °á°ú¸¦ °¡Á®¿À´Â °ÍÀ» ¸»ÇÑ´Ù.
  • hereditary disease
    À¯Àüº´
    À¯ÀüÀÚ¿¡ ÀÇÇÏ¿© ÀϾ´Â ½ÅüÀû, Á¤½ÅÀûÀÎ ÀÌ»óÀÇ ÃÑĪ. À¯Àü¼º ÁúȯÀ̶ó°íµµ ÇÑ´Ù. º´, ÀÌ»ó ÇüÁúÀÌ À¯ÀüÀû ¿äÀΰú °ü·ÃÀÌ ÀÖÀ½¿¡ µû¶ó¼­ ¹Ýµå½Ã À¯ÀüÀÚ¿¡ ÀÇÇÏÁö ¾Ê´Â À¯ÀüÀûÀÎ º´µµ À¯Àüº´À̶ó°í ÇÏ°Ô µÇ¾ú´Ù. 1°³ÀÇ ¿ì¼º À¯ÀüÀÚ¿¡ ÀÇÇÏ¿© ÀϾ´Â ÇåÆÃÅÏ ¹«µµº´, ¹ß·»ºÎ¸£Å© ÁõÈıº, ¿­¼º À¯ÀüÀÚÀÇ µ¿Çü Á¢ÇÕ¿¡ ÀÇÇÏ¿© ³ªÅ¸³ª´Â ¹éÀÚ, Æä´ÒÄÉÅæ´¢Áõ, X ¿°»öü À§ÀÇ ¹Ý¼º À¯ÀüÀÚ¿¡ ÀÇÇÑ Àû·Ï »ö¸Í, Ç÷¿ìº´, ÁøÇ༺ ±Ù µð½ºÆ®·ÎÇÇÁõ µîÀº ¸í¹éÈ÷ ÀÌÀ¯ ÀüÀÚ¿¡ ÀÇÇÑ °ÍÀ¸·Î¼­, À¯Àüº´ÀÇ ´ëÇ¥ÀûÀÎ °ÍÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù. ¹Ý¼º À¯ÀüÀÚ´Â X ¿°»öü À§¿¡ À§Ä¡ÇÏ´Â °Í¸¸ ¾Ë·ÁÁ® ÀÖ°í, ³²¼ºÀ» °áÁ¤ÇÏ´Â Y ¿°»öü À§¿¡´Â ÇöÀç±îÁö ƯÈ÷ È®½ÇÇÑ ÇüÁúÀ» °áÁ¤ÇÏ´Â À¯ÀüÀÚ´Â Á¸ÀçÇÏÁö ¾Ê´Â´Ù°í º¸°í ÀÖ´Ù. À¯ÀüÀÚ¿¡ ÀÇÇÑ ÀÌ»óÀ̳ª º´Àº Ãâ»ýÇÏ´Â ¾Æ±âÀÇ 1 %°¡ ÀÌ¹Ì °¡Áö°í Àְųª ¹ßº´ÇÒ °¡´É¼ºÀ» Áö´Ï°í ÀÖ´Ù. ¿°»öüÀÇ ±¸Á¶ ¶Ç´Â ±¸¼ºÀÇ ÀÌ»ó¿¡ ÀÇÇÏ¿© ÀϾ´Â ¿©·¯ °¡Áö ÀÌ»ó ´Ù¿î ÁõÈıº, ÅÍ³Ê ÁõÈıº, Ŭ¶óÀÎÆçÅÍ ÁõÈıº µîµµ ¿°»öü À§¿¡ À¯ÀüÀÚ°¡ ÀÖ´Ù°í ÇÏ´Â Àǹ̿¡¼­´Â À¯ÀüÇÐÀûÀÎ °ÍÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù. ±×·¯³ª ´ë°³´Â ÀÌ»ó °³Ã¼¸¦ ¸¸µç ¹è¿ìÀÚ
  • HIV associated periodontal disease
    HIV¿Í °ü·ÃµÈ Ä¡ÁÖ Áúȯ
  • HIV disease
    ÀÎü ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º Áúȯ
  • Hodgkin's disease
    È£ÁîŲ º´, È£ÁöŲ º´, Hodgkin º´
    µ¿ÀǾî=malignant lym
  • hunger disease
    ±â¾Æ º´
  • hyaline membrane disease
    À¯¸®Áú¸·º´
    ¹Ì¼÷¾Æ¿¡¼­ Ãâ»ý Á÷ÈÄ ¹ß»ýÇÏ´Â °¡Àå ÈçÇÑ Áúº´ Áß Çϳª·Î¼­ ½Å»ý¾Æ »ç¸ÁÀÇ Áß¿ä ¿øÀÎÁß ÇϳªÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
alpha-cortolone 3a,17a,20a,21-Tetrahydroxy-5b-pregnane-11-one;the 5b enantiomer of alpha-allocortolone; a reduction product of cortisone, present in the urine, differing from cortisone in that two of the keto groups (at positions 3 and 20) are reduced to hydroxyls.
(05 Mar 2000)
alpha-d-galactosidase <enzyme> An enzyme catalyzing the hydrolysis of alpha-d-galactosides to release free d-galactose. A deficiency of type A alpha-d-galactosidase is associated with Fabry's disease.
Synonym: melibiase.
(05 Mar 2000)
alpha-d-glucosidase A glucohydrolase removing terminal nonreducing 1,4-linked alpha-glucose residues by hydrolysis, yielding alpha-glucose; a deficiency of the lysosomal enzyme is associated with glycogen storage disease type II. There are at least five isozymes of maltase.
Synonym: glucoinvertase.
(05 Mar 2000)
alpha-D-mannose-beta-1,2-N-acetylglucosaminyltransferase <enzyme> Absolute specificity for terminal branched mannosyl residues of glycolipids
Registry number: EC 2.4.1.-
Synonym: udpgnac-1,2-magtransferase
(26 Jun 1999)
alpha-D-xylosidase <enzyme> Highly specific for 4-nitrophenyl alpha-d-xylopyranoside and isoprimeverose; can also split off the alpha-d-xylopyranosyl residue on the non-reducing terminal of the backbone of certain oligoxyloglucans
Registry number: EC 3.2.1.-
Synonym: alpha-d-xylosidase I, alpha-d-xylosidase II
(26 Jun 1999)
alpha emission <physics> Form of nuclear decay where the nucleus emits an alpha particle (see entry below).
(09 Oct 1997)
alpha-endorphin <chemical> An endogenous opioid peptide derived from the pro-opiomelanocortin precursor. It differs from gamma-endorphin by one amino acid.
Chemical name: alpha-Endorphin
(12 Dec 1998)
alpha error The statistical error (said to be of the first kind or type I) made in testing an hypothesis when it is concluded that a result is positive when it really is not. Alpha error is often referred to as a false positive.
(12 Dec 1998)
alpha-farnesene 3,7,11-Trimethyl-1,3,6,10-dodecatetraene;a straight open-chain hydrocarbon built up of three isoprene units; one of the four isomeric forms occurs in the natural coating of apples.
(05 Mar 2000)
alpha-fetoprotein <protein, tumour marker> A protein substance that is normally produced by the liver cells.
It is one of the first alpha-globulins to appear in mammalian sera during development of the embryo and the dominant serum proteins in early embryonic life. They reappear in the adult serum during certain pathologic states.
Measurement of the alpha-fetoprotein level in the bloodstream has been used as a early detection test for some forms of cancer (hepatocellular carcinoma). Alpha-fetoprotein can also be an important marker in the fluid obtained by amniocentesis for the prenatal diagnosis of anencephaly and other open neural tube defects such as spina bifida.
Elevated in: wrong dates for a pregnancy, multiple gestation, midline closure (neural-tube) defects, encephalocele, anencephaly, liver tumours, hepatoblastoma, haemangioendothelioma (occasionally, mild), hepatocellular carcinoma (HCC, hepatoma). The level produced by liver tumours (hepatomas), germ cell tumours (teratocarcinoma and embryonal cell carcinomas) permits the monitoring of response to treatment of these tumours.
Decreased in: wrong dates for a pregnancy, chromosome abnormality (including Down syndrome)
Acronym: AFP
(27 Jun 1999)
alpha-fetoproteins Increases in maternal blood during pregnancy and, when detected by amniocentesis, is an important indicator of open neural tube defects and is also used as a tumour marker in adults with hepatocellular carcinoma, beta-fetoproteins, although a foetal liver protein, has been detected in adult patients with liver disease, gamma-fetoproteins occurs in various neoplasms.
See: fetoglobulins.
(05 Mar 2000)
alpha fibres Large somatic motor or proprioceptive nerve fibre's conducting impulses at rates near 100 m/sec.
(05 Mar 2000)
alpha-fucosidase <enzyme> An enzyme that catalyses the hydrolysis of an an alpha-l-fucoside, producing an alcohol and l-fucose; a deficiency of the lysosomal enzyme will result in fucosidosis.
(05 Mar 2000)
alpha-galactosidase <enzyme> An enzyme that catalyses the hydrolysis of terminal, non-reducing alpha-d-galactose residues in alpha-galactosides including galactose oligosaccharides, galactomannans, and galactolipids.
Chemical name: alpha-D-Galactoside galactohydrolase
Registry number: EC 3.2.1.22
(12 Dec 1998)
alpha-globulin <protein> The serum globulins with the most rapid electrophoretic migration, further subdivided into faster alpha(1)- and slower alpha(2)-globulins.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á